Glaukos (GKOS) Operating Income (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -203.45% |
| Dec 31, 2025 | 217.28% |
| Sep 30, 2025 | 27.87% |
| Jun 30, 2025 | -9.73% |
| Mar 31, 2025 | -132.76% |
| Dec 31, 2024 | 355.97% |
| Sep 30, 2024 | 17.73% |
| Jun 30, 2024 | 23.27% |
| Mar 31, 2024 | -1.15% |
| Dec 31, 2023 | -37.89% |
| Sep 30, 2023 | 3.66% |
| Jun 30, 2023 | 11.88% |
| Mar 31, 2023 | 2.20% |
| Dec 31, 2022 | -56.10% |
| Sep 30, 2022 | 41.21% |
| Jun 30, 2022 | -475.41% |
| Mar 31, 2022 | 154.80% |
| Dec 31, 2021 | -262.09% |
| Sep 30, 2021 | 177.51% |
| Jun 30, 2021 | -20.47% |
| Mar 31, 2021 | -3.63% |
| Dec 31, 2020 | 7.77% |
| Sep 30, 2020 | 73.83% |
| Jun 30, 2020 | 10.29% |
| Mar 31, 2020 | -77.16% |
| Dec 31, 2019 | -139.20% |
| Sep 30, 2019 | -98.96% |
| Jun 30, 2019 | -221.65% |
| Mar 31, 2019 | -202.27% |
| Dec 31, 2018 | 127.35% |
| Sep 30, 2018 | -63.30% |
| Jun 30, 2018 | -14.38% |
| Mar 31, 2018 | -798.12% |
| Dec 31, 2017 | -28.88% |
| Sep 30, 2017 | 119.35% |
| Jun 30, 2017 | -1,371.38% |
| Mar 31, 2017 | -35.04% |
| Dec 31, 2016 | -54.56% |
| Sep 30, 2016 | -51.46% |
| Jun 30, 2016 | 241.71% |
| Mar 31, 2016 | 130.97% |
| Dec 31, 2015 | -16.23% |
| Sep 30, 2015 | 67.95% |
| Jun 30, 2015 | -354.56% |
| Mar 31, 2015 | 76.41% |
| Dec 31, 2014 | -166.68% |
| Sep 30, 2014 | 16.13% |
| Jun 30, 2014 | 44.26% |